comparemela.com
Home
Live Updates
Rare Disease Treatment, HYFTOR® (sirolimus topical gel)
Rare Disease Treatment, HYFTOR® (sirolimus topical gel)
Rare Disease Treatment, HYFTOR® (sirolimus topical gel) 0.2% Coverage Expanded by Medicaid, Including in Key U.S. States
/PRNewswire/ -- HYFTOR® (sirolimus topical gel) 0.2%, indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex (TSC) in...
Related Keywords
California ,
United States ,
New York ,
Florida ,
Tokyo ,
Japan ,
Texas ,
Alfred Nobel ,
Nobelpharma America ,
Douglas Loock ,
Sheila Burke ,
Method Health Communications ,
Nobelpharma Co Ltd ,
Vice President ,
Commercial Operations ,
Prescribing Information ,
Facial Angiofibroma Associated ,
Tuberous Sclerosis ,
Patient Information ,
Contact Information ,